Literature DB >> 12482873

Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II.

Gilles Despouy1, Jean-Nöel Bastie, Sylvie Deshaies, Nicole Balitrand, Alexandra Mazharian, Cécile Rochette-Egly, Christine Chomienne, Laurent Delva.   

Abstract

Ligand-induced transcription activation of retinoic acid (RA) target genes by nuclear receptors (retinoic acid (RAR) and retinoid X (RXR) receptors) depends on the recruitment of coactivators. We have previously demonstrated that the small 15-kDa cellular RA-binding protein II (CRABPII) is a coactivator present in the RA-dependent nuclear complex. As identifying cell-specific partners of CRABPII might help to understand the novel control of RA signaling, we performed a yeast two-hybrid screen of a hematopoietic HL-60 cDNA library using human CRABPII as bait and have subsequently identified human cyclin D3 as a partner of CRABPII. Cyclin D3 interacted with CRABPII in a ligand-independent manner and equally bound RAR alpha, but not RXR alpha, and only in the presence of RA. We further show that cyclin D3 positively modulated RA-mediated transcription through CRABPII. Therefore, cyclin D3 may be part of a ternary complex with CRABPII and RAR. Finally, we show that cyclin D3 expression paralleled HL-60 differentiation and arrest of cell growth. These findings led us to speculate that control of cell proliferation during induction of differentiation may directly involve, at the transcriptional level, nuclear receptors, coactivators, and proteins of the cell cycle in a cell- and nuclear receptor-specific manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482873     DOI: 10.1074/jbc.M210697200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

Review 2.  Vitamin D receptor and RXR in the post-genomic era.

Authors:  Mark D Long; Lara E Sucheston-Campbell; Moray J Campbell
Journal:  J Cell Physiol       Date:  2015-04       Impact factor: 6.384

3.  Genetic replacement of cyclin D1 function in mouse development by cyclin D2.

Authors:  Bradley C Carthon; Carola A Neumann; Manjusri Das; Basil Pawlyk; Tiansen Li; Yan Geng; Piotr Sicinski
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma.

Authors:  David A Sarruf; Irena Iankova; Anna Abella; Said Assou; Stéphanie Miard; Lluis Fajas
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

5.  The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.

Authors:  Virginie Ropars; Gilles Despouy; Marc-Henri Stern; Serge Benichou; Christian Roumestand; Stefan T Arold
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

Review 6.  Vitamin A and retinoid signaling: genomic and nongenomic effects.

Authors:  Ziad Al Tanoury; Aleksandr Piskunov; Cécile Rochette-Egly
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

7.  Potential gene regulatory role for cyclin D3 in muscle cells.

Authors:  Fathima Athar; Veena K Parnaik
Journal:  J Biosci       Date:  2015-09       Impact factor: 1.826

8.  A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95.

Authors:  Tatjana Arsenijevic; Chantal Degraef; Jacques E Dumont; Pierre P Roger; Isabelle Pirson
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

9.  The proliferating cell nuclear antigen regulates retinoic acid receptor transcriptional activity through direct protein-protein interaction.

Authors:  Perrine J Martin; Virginie Lardeux; Philippe Lefebvre
Journal:  Nucleic Acids Res       Date:  2005-07-29       Impact factor: 16.971

Review 10.  Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs).

Authors:  Cécile Rochette-Egly; Pierre Germain
Journal:  Nucl Recept Signal       Date:  2009-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.